ATC Group: A05AA02 Ursodeoxycholic acid

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Bile and liver therapy
3
Bile therapy
4
Bile acid preparations
5
A05AA02
Ursodeoxycholic acid

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
750 mg

Active ingredients

Active Ingredient
Description

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones.

Medicines in this ATC group

Drug
Countries

France Ireland United Kingdom

United Kingdom

Netherlands

Ireland Poland

France Germany

Hong Kong

New Zealand

Ecuador

Ecuador

Brazil Italy

Canada United States

Cyprus Hong Kong Italy

Spain Tunisia

Ecuador

Finland Germany Netherlands Spain

Hong Kong

Australia

Australia Austria Cyprus Ecuador Estonia ...

Austria Estonia Ireland Lithuania

France Tunisia

Hong Kong

Austria Germany Netherlands United Kingdom

Australia Estonia Lithuania New Zealand

South Africa

Netherlands

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
IE
Structured Product Labeling (SPL/PLR)
US
Summary of Product Characteristics (SPC)
IE